Navigation Links
WellPoint Announces Appearance at Upcoming Conference
Date:1/7/2009

INDIANAPOLIS, Jan. 7 /PRNewswire/ -- WellPoint, Inc. (NYSE: WLP) announced today that senior management is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference on Jan. 12, 2009, at 9:30 a.m. Pacific Standard Time (12:30 p.m. Eastern Standard Time).

WellPoint, Inc. is scheduled to release earnings results for the three months ended Dec. 31, 2008, on January 28, 2009. WellPoint, Inc. is currently in a quiet period prior to this scheduled earnings release, and therefore management will not be discussing earnings projections at the conference.

All interested parties are invited to listen to a webcast of the presentation by visiting www.wellpoint.com and selecting the "Investor Info" link. Following the presentation, a webcast replay will be available at www.wellpoint.com for two weeks.

To listen to the live webcast, please visit WellPoint's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentation will be presumed to have read WellPoint's most recent filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended Dec. 31, 2007, and its Quarterly Reports on Form 10-Q for the reporting periods of 2008.

About WellPoint, Inc.

WellPoint is committed to improving the lives and health of the people and communities we serve by simplifying the connection between health, care and value. Our goal is to help shape the impact each health care decision has on individuals, the health care system at-large, and our communities. WellPoint's more than 42,000 associates work every day to help create the best health care value for our customers. Through collaborations with providers and with innovative programs, WellPoint's affiliated health plans reward healthy lifestyles and quality, safe and effective care. As the nation's largest health benefits company, with more than 35 million members in its affiliated health plans, WellPoint is at the center of the health care system. This position provides us with the relationships and insights needed to help create affordable and actionable solutions that improve health care.

As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare.

Health. Care. Value. Additional information about WellPoint is available at www.wellpoint.com.


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
2. Healthbase Collaborates with WellPoint to Bring Affordable Medical Tourism Solutions
3. WellPoint to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 28, 2009
4. WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information
5. Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices
6. WellPoint Associates Pledge Record Amount to Community Organizations in 2009
7. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
8. Dr. Charles Kennedy, Vice President of Health Information Technology for WellPoint, Inc., to Present Today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0)
9. WellPoint Announces Second Annual Innovation Event
10. WellPoint Congratulates President-Elect Barack Obama
11. WellPoint Awarded Prestigious International Marketing Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... ... , ... Silicon Valley Hair Institute, the leading hair transplant center in the ... the ARTAS® hair transplant system and the younger demographic. As many younger people suffer ... methods of hair restoration. , “It can be emotionally difficult for young men and ...
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... firm in Pennsylvania, is pleased to offer in-home and online newborn sleep ... sleep deprivation has on the body,” says company owner Courtney Zentz, a pediatric ...
(Date:9/22/2017)... ... , ... “Cursed with a Curse: The Truth about Tithing”: ... experienced when breaking free from this misconception. “Cursed with a Curse: The Truth ... by Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and ...
(Date:9/22/2017)... Francisco, CA (PRWEB) , ... September 22, 2017 ... ... way to help you brush more effectively even on the go. Their electric ... like gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir (formerly ... Spirometer, announced today a partnership with Novartis Pharma AG to ... NuvoAir,s position as the leading mobile spirometry platform and Novartis, ... ... ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
Breaking Medicine Technology: